DarioHealth (NASDAQ:DRIO) Shares Cross Below Two Hundred Day Moving Average – Here’s Why

DarioHealth Corp. (NASDAQ:DRIO)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $11.62 and traded as low as $8.11. DarioHealth shares last traded at $8.11, with a volume of 10,455 shares trading hands.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on DRIO. Wall Street Zen downgraded shares of DarioHealth from a “hold” rating to a “sell” rating in a research report on Sunday, January 25th. Weiss Ratings reissued a “sell (d-)” rating on shares of DarioHealth in a research report on Monday, December 29th. Finally, Stifel Nicolaus lowered their price objective on DarioHealth from $16.00 to $10.00 and set a “buy” rating for the company in a research report on Friday, March 20th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $35.00.

DarioHealth Price Performance

The company has a debt-to-equity ratio of 0.45, a current ratio of 3.76 and a quick ratio of 3.30. The business’s 50 day moving average price is $10.27 and its 200 day moving average price is $11.62. The stock has a market capitalization of $59.20 million, a P/E ratio of -0.78 and a beta of 1.08.

Hedge Funds Weigh In On DarioHealth

Several large investors have recently added to or reduced their stakes in the company. XTX Topco Ltd lifted its position in shares of DarioHealth by 229.0% in the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock valued at $42,000 after acquiring an additional 43,513 shares in the last quarter. Geode Capital Management LLC raised its stake in DarioHealth by 167.9% during the 4th quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock valued at $564,000 after purchasing an additional 31,063 shares during the period. Finally, Kestra Advisory Services LLC bought a new stake in DarioHealth during the 4th quarter valued at approximately $35,000. Hedge funds and other institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.